Literature DB >> 2566488

Biphasic effect of D-2 agonist quinpirole on locomotion and movements.

D Eilam1, H Szechtman.   

Abstract

The effects of the D-2 agonist quinpirole on forward progression, and on vertical and lateral movements, were measured for 2 h in rats injected with either saline, 0.03, 0.125, 0.5 or 8 mg/kg of the drug. Results showed that the drug had a biphasic effect: the lowest dose decreased and the high doses increased the amount of locomotion and of movement. The decrease in activity produced by the low dose had its onset within minutes after administration of the drug; persistent and marked hyperactivity was observed from about 60-80 min after injection of 0.5-8 mg/kg of quinpirole. Moreover, in animals injected with intermediate doses, the excitation was preceded by a brief period of reduced locomotion. It is suggested that the biphasic effect may reflect two independent actions of the drug, possibly on activity in the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566488     DOI: 10.1016/0014-2999(89)90837-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  61 in total

1.  Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine.

Authors:  C A Moody; N A Frambes; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weanling age period.

Authors:  C A Moody; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors.

Authors:  D Eilam; H Talangbayan; G Canaran; H Szechtman
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Drosophila Dopamine2-like receptors function as autoreceptors.

Authors:  Trisha L Vickrey; B Jill Venton
Journal:  ACS Chem Neurosci       Date:  2011-12-21       Impact factor: 4.418

5.  Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI.

Authors:  Christin Y Sander; Jacob M Hooker; Ciprian Catana; Bruce R Rosen; Joseph B Mandeville
Journal:  Neuropsychopharmacology       Date:  2015-09-21       Impact factor: 7.853

6.  Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission.

Authors:  C Sebban; X Q Zhang; B Tesolin-Decros; M J Millan; M Spedding
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

7.  Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice.

Authors:  Ravikumar Ponnusamy; Helen A Nissim; Mark Barad
Journal:  Learn Mem       Date:  2005 Jul-Aug       Impact factor: 2.460

8.  Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments.

Authors:  Anna Dvorkin; Kirsten E Culver; Henry Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2006-05-11       Impact factor: 4.530

9.  Clorgyline-induced modification of behavioral sensitization to quinpirole: effects on local cerebral glucose utilization.

Authors:  Toni L Richards; Thomas L Pazdernik; Beth Levant
Journal:  Brain Res       Date:  2007-05-31       Impact factor: 3.252

10.  Basal local cerebral glucose utilization is not altered after behavioral sensitization to quinpirole.

Authors:  Toni L Richards; Thomas L Pazdernik; Beth Levant
Journal:  Neurosci Lett       Date:  2007-10-18       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.